Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.

[1]  S. Blair,et al.  Changes in fitness and fatness on the development of cardiovascular disease risk factors hypertension, metabolic syndrome, and hypercholesterolemia. , 2012, Journal of the American College of Cardiology.

[2]  S. Bottle,et al.  Novel paramagnetic AT1 receptor antagonists. , 2011, Chemical communications.

[3]  Wilson Fung Fung Pritha Singh,et al.  Focus on Azilsartan: A next-generation angiotensin II receptor blocker for the treatment of hypertension , 2010 .

[4]  P. Herdewijn,et al.  Antibacterial 5'-O-(N-dipeptidyl)-sulfamoyladenosines. , 2009, Bioorganic & medicinal chemistry.

[5]  K. Bothara,et al.  Design, synthesis and pharmacological screening of novel antihypertensive agents using hybrid approach. , 2009, Bioorganic & medicinal chemistry.

[6]  N. Kaur,et al.  Design, synthesis, and evaluation of 5-sulfamoyl benzimidazole derivatives as novel angiotensin II receptor antagonists. , 2008, Bioorganic & medicinal chemistry.

[7]  Rui Wang,et al.  Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring. , 2008, Bioorganic & medicinal chemistry.

[8]  W. Hua,et al.  Synthesis and biological activity of 2-alkylbenzimidazoles bearing a N-phenylpyrrole moiety as novel angiotensin II AT1 receptor antagonists. , 2007, Bioorganic & medicinal chemistry letters.

[9]  Matthew H Todd,et al.  Design and synthesis of new tetrazolyl- and carboxy-biphenylylmethyl-quinazolin-4-one derivatives as angiotensin II AT1 receptor antagonists. , 2006, Journal of medicinal chemistry.

[10]  W. Humphreys,et al.  Dual angiotensin II and endothelin A receptor antagonists: synthesis of 2'-substituted N-3-isoxazolyl biphenylsulfonamides with improved potency and pharmacokinetics. , 2005, Journal of medicinal chemistry.

[11]  M. Menziani,et al.  Design, synthesis, structural studies, biological evaluation, and computational simulations of novel potent AT(1) angiotensin II receptor antagonists based on the 4-phenylquinoline structure. , 2004, Journal of medicinal chemistry.

[12]  J. Macor,et al.  Discovery of 4'-[(imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/angiotensin II receptor antagonists. , 2003, Bioorganic & medicinal chemistry letters.

[13]  Natesan Murugesan,et al.  Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists. , 2002, Journal of medicinal chemistry.

[14]  C. Almansa,et al.  Synthesis and Structure−Activity Relationship of a New Series of Potent AT1 Selective Angiotensin II Receptor Antagonists: 5-(Biphenyl-4-ylmethyl)pyrazoles , 1997 .

[15]  Kathryn L. Murphy,et al.  Potent dual antagonists of endothelin and angiotensin II receptors derived from α-phenoxyphenylacetic acids (Part III) , 1995 .

[16]  K. Balakrishnan,et al.  A simple and rapid method for the preparation of plasma membranes. , 1983, Biochimica et biophysica acta.